BACKGROUND: Hyperglycemia is a marker of poor clinical outcomes in studies evaluating hospitalized critically ill patients. OBJECTIVES: To identify whether glycemic control is associated with health outcomes including acute coronary events, renal failure, infection, hospital length of stay, intensive care unit (ICU) admission, sepsis and mortality in noncritically ill patients administered parenteral nutrition (PN), and to compare the current standard of care for glucose monitoring at the Foothills Medical Centre (Calgary, Alberta) with the 2009 American Society of Parenteral and Enteral Nutrition guidelines. METHODS: A retrospective chart review of 100 adult (18 years of age or older) non-ICU inpatients who received PN for seven days or longer at the Foothills Medical Centre was conducted. RESULTS: Seventeen patients (17%) had a mean blood glucose level of 10.0 mmol/L or greater. PN patients with a mean blood glucose level of 10 mmol/L or greater had a higher rate of mortality than patients with a mean blood glucose level of less than 10 mmol/L (OR 7.22; 95% CI 1.08 to 48.29; P=0.042). Hyperglycemia was independently and significantly associated with mortality when adjusted for age and sex. Acute coronary events, renal failure, infection, hospital length of stay, ventilator use and ICU admissions were not associated with hyperglycemia. Only one-half of those with hyperglycemia, and none of the patients in the euglycemic group, received adequate glucose monitoring during the first two days of PN. CONCLUSION: Hyperglycemia in noncritically ill inpatients receiving PN was found to be a risk factor for increased mortality.
BACKGROUND:Hyperglycemia is a marker of poor clinical outcomes in studies evaluating hospitalized critically ill patients. OBJECTIVES: To identify whether glycemic control is associated with health outcomes including acute coronary events, renal failure, infection, hospital length of stay, intensive care unit (ICU) admission, sepsis and mortality in noncritically ill patients administered parenteral nutrition (PN), and to compare the current standard of care for glucose monitoring at the Foothills Medical Centre (Calgary, Alberta) with the 2009 American Society of Parenteral and Enteral Nutrition guidelines. METHODS: A retrospective chart review of 100 adult (18 years of age or older) non-ICU inpatients who received PN for seven days or longer at the Foothills Medical Centre was conducted. RESULTS: Seventeen patients (17%) had a mean blood glucose level of 10.0 mmol/L or greater. PN patients with a mean blood glucose level of 10 mmol/L or greater had a higher rate of mortality than patients with a mean blood glucose level of less than 10 mmol/L (OR 7.22; 95% CI 1.08 to 48.29; P=0.042). Hyperglycemia was independently and significantly associated with mortality when adjusted for age and sex. Acute coronary events, renal failure, infection, hospital length of stay, ventilator use and ICU admissions were not associated with hyperglycemia. Only one-half of those with hyperglycemia, and none of the patients in the euglycemic group, received adequate glucose monitoring during the first two days of PN. CONCLUSION:Hyperglycemia in noncritically ill inpatients receiving PN was found to be a risk factor for increased mortality.
Authors: G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon Journal: N Engl J Med Date: 2001-11-08 Impact factor: 91.245
Authors: Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco Journal: N Engl J Med Date: 2009-03-24 Impact factor: 91.245
Authors: Guillermo E Umpierrez; Scott D Isaacs; Niloofar Bazargan; Xiangdong You; Leonard M Thaler; Abbas E Kitabchi Journal: J Clin Endocrinol Metab Date: 2002-03 Impact factor: 5.958
Authors: Antonio Ceriello; Lisa Quagliaro; Michele D'Amico; Clara Di Filippo; Raffaele Marfella; Francesco Nappo; Liberato Berrino; Francesco Rossi; Dario Giugliano Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: Donald E G Griesdale; Russell J de Souza; Rob M van Dam; Daren K Heyland; Deborah J Cook; Atul Malhotra; Rupinder Dhaliwal; William R Henderson; Dean R Chittock; Simon Finfer; Daniel Talmor Journal: CMAJ Date: 2009-03-24 Impact factor: 8.262
Authors: Jean L Fry; Brooke D Munson; Katherine L Thompson; Christopher S Fry; Douglas Paddon-Jones; Emily J Arentson-Lantz Journal: Sci Rep Date: 2022-04-27 Impact factor: 4.996
Authors: Gabriel Olveira; María José Tapia; Julia Ocón; Carmen Cabrejas-Gómez; María D Ballesteros-Pomar; Alfonso Vidal-Casariego; Carmen Arraiza-Irigoyen; Josefina Olivares; Maria Del Carmen Conde-García; Alvaro García-Manzanares; Francisco Botella-Romero; Rosa P Quílez-Toboso; Lucio Cabrerizo; Pilar Matia; Luisa Chicharro; Rosa Burgos; Pedro Pujante; Mercedes Ferrer; Ana Zugasti; Javier Prieto; Marta Diéguez; María José Carrera; Anna Vila-Bundo; Juan Ramón Urgelés; Carmen Aragón-Valera; Adela Rovira; Irene Bretón; Pilar García-Peris; Araceli Muñoz-Garach; Efren Márquez; Dolores Del Olmo; José Luis Pereira; María C Tous Journal: Diabetes Care Date: 2012-12-06 Impact factor: 19.112